InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Michael F Maclean, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 13 open-market SEC Form 4 transactions: 0 purchases worth $0 and 13 sales worth $13.1M, reported from Jan 22, 24 to Jan 21, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 21, 26 | RNAAvidity Biosciences, Inc. | SELL | 2.7K | $72.45 | $198K |
| Jan 7, 26 | RNAAvidity Biosciences, Inc. | SELL | 2.0K | $72.23 | $143K |
| Aug 6, 25 | RNAAvidity Biosciences, Inc. | SELL | 30.9K | $42.73 | $1.3M |
| Mar 20, 25 | RNAAvidity Biosciences, Inc. | SELL | 7.9K | $31.06 | $246K |
| Jan 21, 25 | RNAAvidity Biosciences, Inc. | SELL | 1.7K | $28.59 | $48K |
| Dec 18, 24 | RNAAvidity Biosciences, Inc. | SELL | 11.2K | $32.66 | $364K |
| Nov 6, 24 | RNAAvidity Biosciences, Inc. | SELL | 65.2K | $46.22 | $3.0M |
| Sep 23, 24 | RNAAvidity Biosciences, Inc. | SELL | 11.5K | $44.00 | $506K |
| Jun 18, 24 | RNAAvidity Biosciences, Inc. | SELL | 11.2K | $39.13 | $439K |
| Jun 12, 24 | RNAAvidity Biosciences, Inc. | SELL | 104.2K | $35.72 | $3.7M |
| May 14, 24 | RNAAvidity Biosciences, Inc. | SELL | 75.0K | $28.28 | $2.1M |
| Mar 13, 24 | RNAAvidity Biosciences, Inc. | SELL | 40.0K | $24.52 | $981K |
| Jan 22, 24 | RNAAvidity Biosciences, Inc. | SELL | 1.6K | $10.13 | $16K |